Cargando…

Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices — United States, December 2021

Detalles Bibliográficos
Autores principales:	Oliver, Sara E., Wallace, Megan, See, Isaac, Mbaeyi, Sarah, Godfrey, Monica, Hadler, Stephen C., Jatlaoui, Tara C., Twentyman, Evelyn, Hughes, Michelle M., Rao, Agam K., Fiore, Anthony, Su, John R., Broder, Karen R., Shimabukuro, Tom, Lale, Allison, Shay, David K., Markowitz, Lauri E., Wharton, Melinda, Bell, Beth P., Brooks, Oliver, McNally, Veronica, Lee, Grace M., Talbot, H. Keipp, Daley, Matthew F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2022
Materias:	Full Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774160/ https://www.ncbi.nlm.nih.gov/pubmed/35051137 http://dx.doi.org/10.15585/mmwr.mm7103a4

Ejemplares similares

Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices — United States, July 2021
por: Rosenblum, Hannah G., et al.
Publicado: (2021)

Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients — United States, April 2021
por: MacNeil, Jessica R., et al.
Publicado: (2021)

Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine — United States, March–April 2021
por: Shay, David K., et al.
Publicado: (2021)

Janssen/Johnson & Johnson COVID-19 vaccine-related GBS in USA
Publicado: (2021)

The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Janssen COVID-19 Vaccine — United States, February 2021
por: Oliver, Sara E., et al.
Publicado: (2021)

A case report of vaccine-induced immune thrombocytopenia and thrombosis syndrome after Ad26.COV2.S vaccine (Janssen/Johnson & Johnson)()
por: Castan, Maxime, et al.
Publicado: (2022)

The Advisory Committee on Immunization Practices’ Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines — United States, 2021
por: Mbaeyi, Sarah, et al.
Publicado: (2021)

Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions — United States, March–August 2021
por: Self, Wesley H., et al.
Publicado: (2021)

Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021
por: Gargano, Julia W., et al.
Publicado: (2021)

The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5–11 Years — United States, November 2021
por: Woodworth, Kate R., et al.
Publicado: (2021)

Impact of vaccine pause due to Thrombosis with thrombocytopenia syndrome (TTS) following vaccination with the Ad26.COV2.S vaccine manufactured by Janssen/Johnson & Johnson on vaccine hesitancy and acceptance among the unvaccinated population
por: Salmon, Daniel A., et al.
Publicado: (2022)

Life of Johnson /
por: Boswell, James, 1740-1795
Publicado: (1980)

Philip Johnson
por: Jacobus, John M.
Publicado: (1962)

Mister Johnson /
por: Cary, Joyce, 1888-1957
Publicado: (1953)

Samuel Johnson /
por: Wain, John

Johnson’s Cyclopedia
Publicado: (1889)

VITT REACTION ASSOCIATED WITH JOHNSON & JOHNSON COVID-19 VACCINE
por: AKUNA, MELANIE, et al.
Publicado: (2021)

Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines — United States, October 2022
por: Rosenblum, Hannah G., et al.
Publicado: (2022)

The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Moderna COVID-19 Vaccine — United States, December 2020
por: Oliver, Sara E., et al.
Publicado: (2021)

Johnson and Johnson COVID-19 Vaccination Triggering Pheochromocytoma Multisystem Crisis
por: Haji, Nahel, et al.
Publicado: (2021)

ANCA-associated vasculitis following Johnson and Johnson COVID-19 vaccine
por: Yadav, Rukesh, et al.
Publicado: (2022)

The poems of Samuel Johnson
por: Johnson, Samuel, 1709-1784
Publicado: (1974)

El presidente Johnson
por: Singer, Kurt D., 1911-
Publicado: (1965)

THE JOHNSON RECORDING OSCILLOMETER
Publicado: (1959)

Samuel Johnson's gout.
por: Rogers, J P
Publicado: (1986)

P. P. Johnson
Publicado: (1911)

Stevens-Johnson Syndrome
por: Laun, Jake, et al.
Publicado: (2016)

Fielding Johnson of Leicester
Publicado: (1921)

J. N. Johnson
Publicado: (1823)

Johnson’s Universal Cyclopedia
Publicado: (1899)

Johnson’s Operative Dentistry
Publicado: (1915)

Tom Johnson, of Cleveland
Publicado: (1901)

Widespread cutaneous reaction to the Johnson & Johnson Ad26.COV2.S vaccine
por: Sowell, Josiah, et al.
Publicado: (2021)

Transverse myelitis after Johnson & Johnson COVID-19 vaccine: illustrative case
por: Mathew, Ezek, et al.
Publicado: (2022)

The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine — United States, December 2020
por: Oliver, Sara E., et al.
Publicado: (2020)

Interim Recommendation of the Advisory Committee on Immunization Practices for Use of the Novavax COVID-19 Vaccine in Persons Aged ≥18 years — United States, July 2022
por: Twentyman, Evelyn, et al.
Publicado: (2022)

Reply to “Widespread Cutaneous Reaction to the Johnson & Johnson Ad26.Cov2.S Vaccine”
por: Malachowski, Stephen J., et al.
Publicado: (2022)

COVID-19 vaccination preferences during a pause in Johnson & Johnson vaccine administration
por: Wagner, Abram L., et al.
Publicado: (2023)

The lute works of John Johnson
por: Johnson, John, d. 1594 or 5.
Publicado: (1994)

"Síndrome de Stevens-Johnson"
por: Mortera Carbonell, María de los Angeles
Publicado: (1992)

Cannot write session to /tmp/vufind_sessions/sess_7o5fs0566j6vab91ukef1mnel2